Founded in 2018, SEED Biosciences is developing a new enabling tool to make cell and gene therapy a standard of care. Through a Tech Growth loan of CHF 400’000, the Foundation for Technological Innovation (FIT) will fund SEED Biosciences’ sales distribution network expansion in the US to partner with market leaders in lab automation.
